XM does not provide services to residents of the United States of America.

U.S. Analog Devices, Crowdstrike, Workday



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Analog Devices, Crowdstrike, Workday</title></head><body>

Nov 27 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Analog Devices, Crowdstrike and Workday on Wednesday.


HIGHLIGHTS


* Analog Devices Inc ADI.O: TD Cowen cuts target price to $260 from $270

* Crowdstrike CRWD.O: D.A. Davidson raises target price to $395 from $310

* Discover Financial Services DFS.N: Jefferies raises target price to $210 from $173

* Prudential Financial Inc PRU.N: TD Cowen raises target price to $133 from $130

* Workday Inc WDAY.O: Piper Sandler cuts target price to $270 from $285

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Abercrombie & Fitch Co ANF.N: JP Morgan raises target price to $201 from $199

* Alexandria Real Estate Equities Inc ARE.N: JP Morgan cuts PT to $121 from $133

* Alexandria Real Estate Equities Inc ARE.N: JP Morgan cuts to neutral from overweight

* American Express Co AXP.N: Jefferies raises target price to $285 from $260

* Analog Devices Inc ADI.O: Piper Sandler cuts target price to $220 from $235

* Analog Devices Inc ADI.O: TD Cowen cuts target price to $260 from $270

* Arrowhead Pharmaceuticals ARWR.O: Jefferies raises target price to $67 from $65

* Arrowhead Pharmaceuticals ARWR.O: Leerink Partners raises PT to $23 from $20

* Arrowhead Pharmaceuticals ARWR.O: Piper Sandler cuts target price to $45 from $62

* Autodesk Inc ADSK.O: D.A. Davidson raises target price to $275 from $260

* Best buy Co Inc BBY.N: Jefferies cuts target price to $106 from $116

* Best buy Co Inc BBY.N: JP Morgan cuts target price to $115 from $117

* Best buy Co Inc BBY.N: Piper Sandler cuts target price to $102 from $114

* Best buy Co Inc BBY.N: Telsey Advisory Group cuts target price to $110 from $115

* Bread Financial Holdings Inc BFH.N: Jefferies raises target price to $60 from $50

* Burlington Stores Inc BURL.N: Barclays cuts target price to $317 from $327

* Burlington Stores Inc BURL.N: Jefferies raises target price to $332 from $315

* Burlington Stores Inc BURL.N: JP Morgan cuts target price to $342 from $358

* Capital One Financial Corp COF.N: Jefferies raises target price to $215 from $185

* Chewy Inc CHWY.N: JP Morgan raises target price to $37 from $33

* Citius Pharmaceuticals CTXR.O: Maxim Group adjusts PT to $8 from $100 to reflect 1-for-25 reverse stock split

* Crowdstrike CRWD.O: D.A. Davidson raises target price to $395 from $310

* Crowdstrike CRWD.O: JP Morgan raises target price to $372 from $369

* Crowdstrike CRWD.O: Piper Sandler raises target price to $375 from $290

* Crowdstrike CRWD.O: RBC cuts target price to $365 from $370

* Dick's Sporting Goods Inc DKS.N: Jefferies cuts target price to $217 from $225

* Dick's Sporting Goods Inc DKS.N: JP Morgan raises target price to $230 from $215

* Discover Financial Services DFS.N: Jefferies raises target price to $210 from $173

* Discover Financial Services DFS.N: TD Cowen raises target price to $194 from $162

* Eagle Materials Inc EXP.N: JP Morgan raises target price to $310 from $290

* Edwards Lifesciences Corp EW.N: RBC raises target price to $80 from $75

* Enanta Pharmaceuticals Inc ENTA.O: JP Morgan cuts target price to $9 from $10

* Enanta Pharmaceuticals Inc ENTA.O: Leerink Partners cuts PT to $10 from $12

* Fluence Energy Inc FLNC.O: Piper Sandler raises target price to $20 from $18

* Fluence Energy Inc FLNC.O: RBC cuts target price to $27 from $28

* HP Inc HPQ.N: JP Morgan cuts target price to $40 from $41

* Iron Mountain Inc IRM.N: RBC raises target price to $139 from $135

* J M Smucker Co SJM.N: Jefferies raises target price to $130 from $116

* J M Smucker Co SJM.N: JP Morgan raises target price to $136 from $122

* Kohls KSS.N: Jefferies cuts target price to $15 from $19

* Kohls KSS.N: TD Cowen cuts target price to $16 from $20

* M&T Bank Corp MTB.N: Piper Sandler raises target price to $243 from $205

* Martin Marietta Materials Inc MLM.N: JP Morgan raises PT to $640 from $515

* Martin Marietta Materials Inc MLM.N: JP Morgan raises to overweight from neutral

* Marvell Technology Inc MRVL.O: Jefferies raises target price to $110 from $90

* Metlife Inc MET.N: TD Cowen raises target price to $99 from $97

* Mp Materials Corp MP.N: Canaccord Genuity raises target price to $26 from $23

* Newmont NEM.N: TD Cowen cuts target price to $48 from $53

* Nordstrom Inc JWN.N: Jefferies raises target price to $23 from $20

* Nordstrom Inc JWN.N: JP Morgan raises target price to $21 from $20

* Nutanix Inc NTNX.O: JP Morgan raises target price to $83 from $75

* Nutanix Inc NTNX.O: Piper Sandler raises target price to $83 from $77

* Pagerduty Inc PD.N: JP Morgan raises target price to $21 from $20

* Pagerduty Inc PD.N: RBC raises target price to $24 from $22

* Privia Health Group Inc PRVA.O: Jefferies raises target price to $26 from $25

* Prudential Financial Inc PRU.N: TD Cowen raises target price to $133 from $130

* Sarepta Therapeutics Inc SRPT.O: Piper Sandler cuts target price to $182 from $200

* Stepstone Group Inc STEP.O: JP Morgan raises target price to $78 from $69

* Synchrony Financial SYF.N: Jefferies raises target price to $75 from $65

* Urban Outfitters Inc URBN.O: Barclays raises target price to $51 from $43

* Urban Outfitters Inc URBN.O: Jefferies raises target price to $36 from $34

* Urban Outfitters Inc URBN.O: JP Morgan raises target price to $46 from $42

* Valley National Bancorp VLY.O: KBW raises target price to $11.50 from $10.50

* Virtus Investment Partners Inc VRTS.N: Piper Sandler raises PT to $274 from $264

* Vulcan Materials Co VMC.N: JP Morgan raises target price to $290 from $245

* Workday Inc WDAY.O: Barclays cuts target price to $305 from $314

* Workday Inc WDAY.O: D.A. Davidson cuts target price to $260 from $270

* Workday Inc WDAY.O: Piper Sandler cuts target price to $270 from $285

* Workday Inc WDAY.O: Piper Sandler cuts to neutral from overweight


(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.